ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Category : Search result: pharmaceutical innovation
Morning After Pill May Combat Cancer Cells
Groundbreaking research reveals the morning after pill's unexpected potential in cancer prevention, with scientists discovering levonorgestrel's ability to combat deadly diseases.
Pregnancy Drug Scandal Victims Demand Justice
Exclusive investigation reveals how Primodos victims continue fighting for compensation and recognition after pregnancy test drug caused devastating birth defects.
Cholesterol drug cancer risk study reveals alarming findings
Groundbreaking research suggests widely prescribed cholesterol medication may have unexpected side effects, raising concerns among medical professionals and patients across the UK.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
Kimberly-Clark in Merger Talks with Kenvue
In a seismic shift for consumer healthcare, household goods titan Kimberly-Clark is reportedly in advanced discussions to acquire Kenvue, the company behind Tylenol and Band-Aid, in a deal that could reshape the global market.
Fake Weight Loss Jabs Scam: UK Health Warning
Exclusive investigation reveals sophisticated fraud operations selling counterfeit weight loss injections like Ozempic, putting British consumers at serious health risk.
UK probes Pfizer and Novo Nordisk investments
The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
FDA Recalls Blood Pressure Drug Over Cancer Risk
Patients across the UK prescribed Prazosin for blood pressure or prostate issues face urgent medication recall after FDA discovers dangerous carcinogens in tablets. Multiple manufacturers affected.
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
Blood Pressure Drug Recalled Over Contamination Fears
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Alan Kilburn: Pharmacy Visionary Who Revolutionised Medicine
Celebrating the extraordinary life of pharmacist Alan Kilburn, whose pioneering work revolutionised medicine dispensing and championed patient care across the UK.
Novo Nordisk bids for obesity biotech Metsera, challenging Pfizer
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
Ireland faces €13.4bn corporate tax shortfall
Ireland's Department of Finance confronts a staggering €13.4bn corporate tax shortfall as tech and pharmaceutical giants see profits decline, threatening the nation's economic stability.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Pharmacy Visionary Robert Wilkinson Dies at 86
Tributes pour in for pioneering pharmacist Robert Wilkinson, whose groundbreaking work revolutionised NHS patient care and established new standards for community pharmacy across Britain.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
GSK shares tumble nearly 10% on HIV drug trial results
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
UK productivity downgrade sparks tax rise fears
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Sprayable Dessert Trend Sweeps Britain
Discover the viral sprayable dessert trend transforming how Brits experience sweetness. From edible perfumes to calorie-conscious indulgence, this innovative approach to treats is taking social media by storm.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
Page 1 of 4